Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 -- 1214 2023-10-31 11:45:26 |
2 format correct Meta information modification 1214 2023-11-01 01:59:42 |

Video Upload Options

Do you have a full video?

Confirm

Are you sure to Delete?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Xia, Y.; Li, Y.; Shen, W.; Yang, H.; Chen, X. Applications of CRISPR Systems in Saccharomyces cerevisiae. Encyclopedia. Available online: https://encyclopedia.pub/entry/50983 (accessed on 04 September 2024).
Xia Y, Li Y, Shen W, Yang H, Chen X. Applications of CRISPR Systems in Saccharomyces cerevisiae. Encyclopedia. Available at: https://encyclopedia.pub/entry/50983. Accessed September 04, 2024.
Xia, Yuanyuan, Yujie Li, Wei Shen, Haiquan Yang, Xianzhong Chen. "Applications of CRISPR Systems in Saccharomyces cerevisiae" Encyclopedia, https://encyclopedia.pub/entry/50983 (accessed September 04, 2024).
Xia, Y., Li, Y., Shen, W., Yang, H., & Chen, X. (2023, October 31). Applications of CRISPR Systems in Saccharomyces cerevisiae. In Encyclopedia. https://encyclopedia.pub/entry/50983
Xia, Yuanyuan, et al. "Applications of CRISPR Systems in Saccharomyces cerevisiae." Encyclopedia. Web. 31 October, 2023.
Applications of CRISPR Systems in Saccharomyces cerevisiae
Edit

The clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein (CRISPR-Cas) system has undergone substantial and transformative progress. CRISPR-Cas is widely applied in both eukaryotic and prokaryotic hosts, and its powerful gene editing efficiency has also facilitated the construction of microbial cell factories for the production of target compounds. Among various microbial host cells, Saccharomyces cerevisiae stands out due to its uncomplicated structure and post-translational modification system.

gene editing tools CRISPR-Cas Saccharomyces cerevisiae

1. Genome Editing

In the model engineering strain, S. cerevisiae, CRISPR systems have been researched more deeply compared with those in other types of yeast. Using CRISPR strategies for gene editing in S. cerevisiae typically involves the following steps, including selecting a target gene, designing sgRNA sequences, constructing plasmids containing CRISPR elements, marker gene, and homology arms, transforming the plasmids or linearized DNA fragments along with donor DNA, and conducting selection and verification processes. From the initial research on the tolerance of Cas9 and guide RNA (gRNA) mismatches in vivo and in vitro to today’s study [1], many related genetic tools are becoming mature, such as some vector toolboxes: MoClo-based yeast chromosome modification kit [2], unmarked and commercialized EasyClone-MarkerFree [3], and a controllable copy number plasmid [4] constructed with dominant markers. Regarding the effects of CRISPR-relevant tools, researchers can knock out fragments over 30 kb in S. cerevisiae [5]. By using the delta site as a targeting site, the Di-CRISPR platform can integrate up to 18 copies of the gene in one step [6]. In addition, the CRISPR Cas9 system can construct auxotrophic mutants of industrial tetraploid yeast strains [7]. In the research of S. cerevisiae genomics, mCRISPR combined CRISPR-Cas9 and transformation-associated recombination (TAR) to enable single-marker multiplexed promoter engineering of large gene clusters, which enabled efficient multiplexed engineering of natural product biosynthetic gene clusters [8].

2. Genome Library Screening

Efficient screening of ideal industrial yeast strains depends on the establishment of related libraries. Taking advantage of Cas9 mutants with confirmed genetic variations (deletion, substitution, and insertion) in yeast, a genome-wide library established in S. cerevisiae-short, trackable, integrated cellular barcodes (MAGESTIC) achieved saturation editing of the essential gene SEC14, identifying amino acids highly related to inhibiting lipid signaling [9]. Guo and colleagues integrated next-generation sequencing technology (NGS) to construct a genome library targeting 315 small open reading frames with unclear characteristics in the yeast genome, which evaluated genes crucial for growth in various environments [10]. S. cerevisiae is an industrial strain commonly used for the production of ethanol. Liu and colleagues have constructed a Global Regulatory Network (MINR) with 43,020 specific mutations of 25 regulatory genes and identified yeast strains with improved ethanol tolerance [11].

3. Transcription Regulation

Common transcription regulation systems in eukaryotic cells can be divided into three generations [12], all of which use Cas proteins lacking endonuclease activity. For example, dCas9 can be obtained by mutating specific amino acids in the RuvC and HNH functional domains [13]. Similarly, other types of Cas proteins can also be utilized for transcriptional regulation [12]. The principle of the first-generation transcription control system is that when Cas protein is co-expressed with sgRNA, a DNA recognition complex is produced, and then it becomes a roadblock in the transcription process. Furthermore, fusion expression of transcription activator or transcription repressor with dCas9 can achieve gene activation or inhibition. Differently, compared with the additional modification of dCas9 in the first generation, the second generation used a special scaffold RNA to recruit specific effectors. The formed RNA aptamer–RBP pair could regulate the transcription of target genes [14]. The third-generation system is a dimerization system controlled by chemistry and light, further realizing the temporal and spatial control of gene functions.
In recent years, dCas9 has been widely applied in the regulation of the yeast metabolic network. In the glycerol synthesis pathway, by changing the target position of sgRNA, dCas9 can be used to express genes in stages (activation or inhibition) and test systematically enzyme perturbation sensitivity (STEPS) [15], in order to identify the rate-limiting steps in the metabolic pathway. dCas9 can not only fulfill individual inhibition or activation, but also achieved orthogonal transcriptional activation, transcriptional interference, and gene deletion (CRISPRAID). The three-function system containing Cas9 proteins from different sources could modularly, parallelly regulate and interfere with the metabolic network in high-throughput ways. After optimizing different combinations of inactivated nucleases, activators and inhibitors, the production of β-carotene could be increased by three times [16]. A more powerful synthetic biology tool, multi-functional genome-wide CRISPR system (MAGIC), can precisely control the defined genes in the genome. It has great application prospects in the genome-scale engineering of advanced eukaryotes [17].
Beyond the spatial level, synthetic biological elements can realize real-time gene regulation. Researchers have constructed and compared two dCas9-mediated systems, constitutive and inducible, with different gRNA design strategies. In this way, high production of isoprenoids was achieved and production of triglycerides was greatly improved [18].

4. Base Editing

As dCas9 and Cas9 nickase (D10A) will not cause DNA double-strand breaks, fusion expression of their functional domains with adenine/cytidine deaminase can change the corresponding DNA bases and achieve single-base editing [19]. Earlier, through the fusion of CRISPR/Cas9 lacking nuclease activity and activation-induced cytidine deaminase (AID) orthologs, the artificial synthetic complex (Target-AID) [20] can work efficiently in yeast, while in mammalian cells, Uracil DNA glycosidase inhibitors (UGI) are needed to inhibit insertions and deletions.
In addition to the developed adenine base editor ABEs [21] without causing double-strand DNA breaks, Liu and colleagues have recently built a single-base editing system [22][23], which brought a milestone breakthrough in the field of gene editing. The simplest system only contained engineered reverse transcriptase, Cas9 nickase and the guide RNA. It directly wrote new genetic information into the designated position of DNA in eukaryotic cells. Since many human diseases are related to single-base mutations, the CRISPR system has been demonstrated the potential to correct known pathogenic human genetic variants in the medical field.

5. Logic Circuit Control

By means of connecting genetic components, a genetic circuit with complex logic functions can be constructed. In order to solve the problem of the signal degradation when layered in dCas9 system, the NOR gate developed in S. cerevisiae based on dCas9-Mix1 has been established [24]. In a single-gene NOR logic gate, the input and output signals of the gate are programmable signal molecules-gRNAs of the same molecular type. The input end is composed of RNA Pol II pGRR promoter, and the output end is the gRNA transcript flanking with self-splicing ribozyme (RGR). On the basis of this, the NOR gate is integrated into a single yeast genome, and the fluorescent protein intensity at the output end was the signal comparing the effects of different logic circuits. It was found that digital logic circuits with up to seven gRNAs, five NOR gates, and up to seven ladders could be constructed.
In addition, in S. cerevisiae, an AND logic gate was developed with a transcription activation system composed of MCP-VP64, scRNA, and dCas9 [25]. The AND logic gate consisted of two switches, and activating two independent switches made the reporter gene express. The endogenous Gal10 regulated by galactose and the heterologous transcription factor LexA-ER-AD regulated by β-estradiol controlled the constitutively expressed RNA scaffold. It is worth mentioning that the system utilized ribosome skipping T2A sequence to bind target gene and fluorescent reporter gene. This peptide could make a transcript translate multiple proteins due to ribosome jumping, so as to adapt to any target gene and ensure the reporting function simultaneously.

References

  1. Fu, B.X.H.; Onge, R.P.S.; Fire, A.Z.; Smith, J.D. Distinct patterns of Cas9 mismatch tolerance in vitro and in vivo. Nucleic Acids Res. 2016, 44, 5365–5377.
  2. Lee, M.E.; DeLoache, W.C.; Cervantes, B.; Dueber, J.E. A Highly Characterized Yeast Toolkit for Modular, Multipart Assembly. ACS Synth. Biol. 2015, 4, 975–986.
  3. Jessop-Fabre, M.M.; Jakociunas, T.; Stovicek, V.; Dai, Z.; Jensen, M.K.; Keasling, J.D.; Borodina, I. EasyClone-MarkerFree: A vector toolkit for marker-less integration of genes into Saccharomyces cerevisiae via CRISPR-Cas9. Biotechnol. J. 2016, 11, 1110–1117.
  4. Lian, J.; Jin, R.; Zhao, H. Construction of Plasmids With Tunable Copy Numbers in Saccharomyces cerevisiae and Their Applications in Pathway Optimization and Multiplex Genome Integration. Biotechnol. Bioeng. 2016, 113, 2462–2473.
  5. Hao, H.; Wang, X.; Jia, H.; Yu, M.; Zhang, X.; Tang, H.; Zhang, L. Large fragment deletion using a CRISPR/Cas9 system in Saccharomyces cerevisiae. Anal. Biochem. 2016, 509, 118–123.
  6. Shi, S.; Liang, Y.; Zhang, M.M.; Ang, E.L.; Zhao, H. A highly efficient single-step, markerless strategy for multi-copy chromosomal integration of large biochemical pathways in Saccharomyces cerevisiae. Metab. Eng. 2016, 33, 19–27.
  7. Zhang, G.-C.; Kong, I.I.; Kim, H.; Liu, J.-J.; Cate, J.H.D.; Jin, Y.-S. Construction of a Quadruple Auxotrophic Mutant of an Industrial Polyploid Saccharomyces cerevisiae Strain by Using RNA-Guided Cas9 Nuclease. Appl. Environ. Microbiol. 2014, 80, 7694–7701.
  8. Kang, H.-S.; Charlop-Powers, Z.; Brady, S.F. Multiplexed CRISPR/Cas9-and TAR-Mediated Promoter Engineering of Natural Product Biosynthetic Gene Clusters in Yeast. ACS Synth. Biol. 2016, 5, 1002–1010.
  9. Roy, K.R.; Smith, J.D.; Vonesch, S.C.; Lin, G.; Tu, C.S.; Lederer, A.R.; Chu, A.; Suresh, S.; Nguyen, M.; Horecka, J.; et al. Multiplexed precision genome editing with trackable genomic barcodes in yeast. Nat. Biotechnol. 2018, 36, 512–520.
  10. Guo, X.; Chavez, A.; Tung, A.; Chan, Y.; Kaas, C.; Yin, Y.; Cecchi, R.; Garnier, S.L.; Kelsic, E.D.; Schubert, M.; et al. High-throughput creation and functional profiling of DNA sequence variant libraries using CRISPR-Cas9 in yeast. Nat. Biotechnol. 2018, 36, 540–546.
  11. Liu, R.; Liang, L.; Choudhury, A.; Garst, A.D.; Eckert, C.A.; Oh, E.J.; Winkler, J.; Gill, R.T. Multiplex navigation of global regulatory networks (MINR) in yeast for improved ethanol tolerance and production. Metab. Eng. 2019, 51, 50–58.
  12. Xu, X.; Qi, L.S. A CRISPR-dCas Toolbox for Genetic Engineering and Synthetic Biology. J. Mol. Biol. 2019, 431, 34–47.
  13. Roman, E.; Coman, I.; Prieto, D.; Alonso-Monge, R.; Pla, J. Implementation of a CRISPR-Based System for Gene Regulation in Candida albicans. Msphere 2019, 4, 10–1128.
  14. Zalatan, J.G.; Lee, M.E.; Almeida, R.; Gilbert, L.A.; Whitehead, E.H.; La Russa, M.; Tsai, J.C.; Weissman, J.S.; Dueber, J.E.; Qi, L.S.; et al. Engineering Complex Synthetic Transcriptional Programs with CRISPR RNA Scaffolds. Cell 2015, 160, 339–350.
  15. Deaner, M.; Alper, H.S. Systematic testing of enzyme perturbation sensitivities via graded dCas9 modulation in Saccharomyces cerevisiae. Metab. Eng. 2017, 40, 14–22.
  16. Lian, J.; HamediRad, M.; Hu, S.; Zhao, H. Combinatorial metabolic engineering using an orthogonal tri-functional CRISPR system. Nat. Commun. 2017, 8, 1688.
  17. Lian, J.; Schultz, C.; Cao, M.; HamediRad, M.; Zhao, H. Multi-functional genome-wide CRISPR system for high throughput genotype-phenotype mapping. Nat. Commun. 2019, 10, 5794.
  18. Jensen, E.D.; Ferreira, R.; Jakociunas, T.; Arsovska, D.; Zhang, J.; Ding, L.; Smith, J.D.; David, F.; Nielsen, J.; Jensen, M.K.; et al. Transcriptional reprogramming in yeast using dCas9 and combinatorial gRNA strategies. Microb. Cell Factories 2017, 16, 46.
  19. Eid, A.; Alshareef, S.; Mahfouz, M.M. CRISPR base editors: Genome editing without double-stranded breaks. Biochem. J. 2018, 475, 1955–1964.
  20. Nishida, K.; Arazoe, T.; Yachie, N.; Banno, S.; Kakimoto, M.; Tabata, M.; Mochizuki, M.; Miyabe, A.; Araki, M.; Hara, K.Y.; et al. Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science 2016, 353, aaf8729.
  21. Gaudelli, N.M.; Komor, A.C.; Rees, H.A.; Packer, M.S.; Badran, A.H.; Bryson, D.I.; Liu, D.R. Programmable base editing of A.T to G.C in genomic DNA without DNA cleavage. Nature 2017, 551, 464–471.
  22. Anzalone, A.V.; Randolph, P.B.; Davis, J.R.; Sousa, A.A.; Koblan, L.W.; Levy, J.M.; Chen, P.J.; Wilson, C.; Newby, G.A.; Raguram, A.; et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 2019, 576, 149–157.
  23. Rees, H.A.; Liu, D.R. Base editing: Precision chemistry on the genome and transcriptome of living cells. Nat. Rev. Genet. 2018, 19, 770–788.
  24. Gander, M.W.; Vrana, J.D.; Voje, W.E.; Carothers, J.M.; Klavins, E. Digital logic circuits in yeast with CRISPR-dCas9 NOR gates. Nat. Commun. 2017, 8, 15459.
  25. Hofmann, A.; Falk, J.; Prangemeier, T.; Happel, D.; Koeber, A.; Christmann, A.; Koeppl, H.; Kolmar, H. A tightly regulated and adjustable CRISPR-dCas9 based AND gate in yeast. Nucleic Acids Res. 2019, 47, 509–520.
More
Information
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register : , , , ,
View Times: 337
Revisions: 2 times (View History)
Update Date: 01 Nov 2023
1000/1000
ScholarVision Creations